Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with E
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q4 2023 | EDETATE DISODIUM | RECTAL | SOLUTION | NA | MDE Replacement | ||
| Q1 2024 | EDETATE DISODIUM | RECTAL | SOLUTION | 97mg | MDE Replacement | ||
| Q4 2023 | EDETATE DISODIUM | TOPICAL | LOTION | 0.12 %w/v | MDE Replacement | ||
| Q1 2024 | EDETATE DISODIUM | TOPICAL | LOTION | 4mg | MDE Replacement | ||
| Q4 2023 | EDETATE DISODIUM | TOPICAL | SOLUTION | 0.05 %w/v | MDE Replacement | ||
| Q1 2024 | EDETATE DISODIUM | TOPICAL | SOLUTION | 1mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024